Vicky Whittemore

6.6k total citations · 2 hit papers
35 papers, 2.7k citations indexed

About

Vicky Whittemore is a scholar working on Psychiatry and Mental health, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vicky Whittemore has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 13 papers in Physiology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vicky Whittemore's work include Epilepsy research and treatment (19 papers), Tuberous Sclerosis Complex Research (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Vicky Whittemore is often cited by papers focused on Epilepsy research and treatment (19 papers), Tuberous Sclerosis Complex Research (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Vicky Whittemore collaborates with scholars based in United States, Germany and Australia. Vicky Whittemore's co-authors include Petrus J. de Vries, Е. Д. Белоусова, David Lebwohl, Gaurav Shah, Michael Frost, Tarek Sahmoud, Steven Sparagana, David Neal Franz, Loren Leclezio and Anna Jansen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Vicky Whittemore

35 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

2013 629 citations John J. Bissler, J.C. Kingswood et al. The Lancet profile →
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

2012 578 citations David Neal Franz, Е. Д. Белоусова et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vicky Whittemore United States	19	1.6k	682	648	446	396	35	2.7k
Michael Frost United States	21	1.6k 1.0×	694 1.0×	651 1.0×	629 1.4×	381 1.0×	66	3.2k
Anna Jansen Belgium	29	620 0.4×	733 1.1×	282 0.4×	129 0.3×	482 1.2×	122	2.6k
Carolyn M. Hustad United States	29	799 0.5×	1.2k 1.7×	540 0.8×	351 0.8×	249 0.6×	51	2.9k
Christopher R. Pierson United States	31	336 0.2×	1.1k 1.7×	499 0.8×	366 0.8×	54 0.1×	103	2.9k
Christine M. Eng United States	34	2.7k 1.7×	1.3k 1.9×	142 0.2×	234 0.5×	262 0.7×	81	5.7k
Sebastián Morán Spain	35	379 0.2×	3.4k 4.9×	524 0.8×	379 0.8×	204 0.5×	70	4.6k
Mary Kay Koenig United States	21	558 0.3×	1.1k 1.7×	178 0.3×	75 0.2×	136 0.3×	61	2.0k
Fuki M. Hisama United States	22	703 0.4×	2.2k 3.3×	238 0.4×	92 0.2×	79 0.2×	78	3.5k
Adrian Smith United States	22	572 0.4×	549 0.8×	288 0.4×	165 0.4×	493 1.2×	50	1.6k
Leslie A. Lange United States	31	391 0.2×	1.2k 1.7×	193 0.3×	274 0.6×	65 0.2×	87	3.0k

Countries citing papers authored by Vicky Whittemore

Since Specialization

Citations

This map shows the geographic impact of Vicky Whittemore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Whittemore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Whittemore more than expected).

Fields of papers citing papers by Vicky Whittemore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Whittemore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Whittemore. The network helps show where Vicky Whittemore may publish in the future.

Co-authorship network of co-authors of Vicky Whittemore

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Whittemore. A scholar is included among the top collaborators of Vicky Whittemore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Whittemore. Vicky Whittemore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knowles, Juliet K., Ingo Helbig, Cameron S. Metcalf, et al.. (2022). Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia. 63(10). 2461–2475. 65 indexed citations

Vliet, Erwin A. van, Michael S. Hildebrand, James D. Mills, et al.. (2022). A companion to the preclinical common data elements for genomics, transcriptomics, and epigenomics data in rodent epilepsy models. A report of the TASK3‐WG4 omics working group of the ILAE/AES joint translational TASK force. Epilepsia Open. 10(S1). S183–S205. 1 indexed citations

Marsh, Eric D., et al.. (2021). The 2021 Epilepsy Research Benchmarks—Respecting Core Principles, Reflecting Evolving Community Priorities. Epiliepsy currents. 21(5). 389–393. 6 indexed citations

Simonato, Michele, Denes V. Agoston, Amy R. Brooks‐Kayal, et al.. (2021). Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap. Nature Reviews Neurology. 17(4). 231–242. 62 indexed citations

Traynelis, Stephen F., Dennis Dlugos, David C. Henshall, et al.. (2020). Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epiliepsy currents. 20(1_suppl). 23S–30S. 8 indexed citations

Jones, Jana E., Miya R. Asato, Mesha‐Gay Brown, et al.. (2020). Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span. Epiliepsy currents. 20(1_suppl). 31S–39S. 7 indexed citations

Burns, Kristin M., Carri Cottengim, Alexa B. Erck Lambert, et al.. (2020). Epidemiology of Sudden Death in a Population-Based Study of Infants and Children. SHILAP Revista de lepidopterología. 2. 100023–100023. 14 indexed citations

Chang, Bernard S., Vaishnav Krishnan, Chris G. Dulla, et al.. (2020). Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions. Epiliepsy currents. 20(1_suppl). 5S–13S. 10 indexed citations

Correa, Daniel J., Churl‐Su Kwon, Brandy Fureman, et al.. (2018). Applying participatory action research in traumatic brain injury studies to prevent post-traumatic epilepsy. Neurobiology of Disease. 123. 137–144. 6 indexed citations

10.

Burns, Kristin M., Lena Camperlengo, Carri Cottengim, et al.. (2017). The Sudden Death in the Young Case Registry: Collaborating to Understand and Reduce Mortality. PEDIATRICS. 139(3). 33 indexed citations

11.

Leclezio, Loren, Anna Jansen, Vicky Whittemore, & Petrus J. de Vries. (2014). Pilot Validation of the Tuberous Sclerosis-Associated Neuropsychiatric Disorders (TAND) Checklist. Pediatric Neurology. 52(1). 16–24. 85 indexed citations

12.

Koh, Howard K., et al.. (2014). Toward an Integrated Public Health Approach for Epilepsy in the 21st Century. Preventing Chronic Disease. 11. E146–E146. 25 indexed citations

13.

Vries, Petrus J. de, Vicky Whittemore, Loren Leclezio, et al.. (2014). Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist. Pediatric Neurology. 52(1). 25–35. 200 indexed citations

14.

Hashmi, S. Shahrukh, Mary Kay Koenig, Vicky Whittemore, et al.. (2013). Self-reported reproductive health in women with tuberous sclerosis complex. Genetics in Medicine. 15(12). 966–971. 3 indexed citations

15.

Bissler, John J., J.C. Kingswood, Elżbieta Radzikowska, et al.. (2013). Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. 381(9869). 817–824. 629 indexed citations breakdown →

16.

Franz, David Neal, Е. Д. Белоусова, Steven Sparagana, et al.. (2012). Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. The Lancet. 381(9861). 125–132. 578 indexed citations breakdown →

17.

Wheless, James W., et al.. (2012). Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatrics. 12(1). 108–108. 41 indexed citations

18.

Ehninger, Dan, Yoshitake Sano, Petrus J. de Vries, et al.. (2010). Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Molecular Psychiatry. 17(1). 62–70. 85 indexed citations

19.

Au, Kit Sing, E. Steve Roach, Lori Batchelor, et al.. (2007). Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genetics in Medicine. 9(2). 88–100. 296 indexed citations

20.

Whittemore, Vicky, et al.. (2000). National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex. Archives of Neurology. 57(5). 662–662. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact